JudahDFriedmanMD

Oncology • West Palm Beach, FL

Physician

Join to view full profile

Dr. Friedman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Friedman's full profile

Already have an account?

Office
1309 N Flagler Dr
West Palm Beach, FL 33401
Phone+1 561-366-4100

Fax+1 855-288-2991

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2004 - 2007
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2001 - 2004
Case Western Reserve University School of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2022 - 2026
OH State Medical License 2007 - 2023
MI State Medical License 2004 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

29 citations
Clinical utility of reflex testing using focused next-generation sequencing for management of patients with advanced lung adenocarcinoma.
Tyler E. Miller, Michael Yang, David L. Bajor, Judah D. Friedman, Richard Y C Chang
Journal of Clinical Pathology. 2018-09-17
14 citations
Acquired Hemophilia A After Nivolumab Therapy in a Patient With Metastatic Squamous Cell Carcinoma of the Lung Successfully Managed With Rituximab.
Hamza N. Gokozan, Judah Friedman, Alvin H. Schmaier, Katharine A. Downes, Lisa A. Farah
Clinical Lung Cancer. 2019-06-26
19 citations
Change in markers of bone metabolism with chemotherapy for advanced prostate cancer: interleukin-6 response is a potential early indicator of response to therapy.
Kathleen M. Woods Ignatoski, Judah Friedman, June Escara-Wilke, Xiaohua Zhang, Stephanie Daignault
Journal of Interferon & Cytokine Research. 2009-02-01

Lectures

Brentuximab Vedotin in Combination with Nivolumab, Doxorubucin, and Dacarbazine in Newly Diagnosed Patients with Advanced Stage Hodgkin Lymphoma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

A Drive-in Theater Comes to Ridgefield and Other Community NewsJune 9th, 2020